L-Lysinate for Health & Longevity

Created on 11/07/2026 – Quick Reference based on Evidence Review created using AI4L + evidence-mcp / Opus 5.5 – Audit

L-lysinate is a salt of lysine, an amino acid humans cannot make, found in mineral supplements and some pain relievers, of interest for cold sores, stress and calcium uptake. Cold-sore prevention remains contested; stress, calcium and blood-sugar signals rest on small, often indirect studies. Up to about six grams daily appears well tolerated; kidney health is the main open safety question; for health-focused adults, expected gains are modest and uncertain. (Full Review)

Protocol

Cold-sore prevention dose
1–3 g/day
Commonly split two to three times daily, with meals; 624 mg/day not effective
Upper bound
6.0 g/day
Proposed highest dose without observed harm, industry-linked
Mineral and drug lysinates
Dosed by mineral or drug label
Lysine intake follows the mineral dose; drug lysinates on an empty stomach for the fastest onset
Time to effect
Pain relief (ibuprofen lysinate)
Within 2 hours
Blood levels peak in about 30 minutes when fasting
Cold sores
6–12 months
Length of cold-sore trials; any benefit appears tied to ongoing use
Anxiety
1 week to 3 months
Changes appeared after 1 week with lysine plus arginine, 3 months with fortified wheat

Benefits

Contraindications
  • Kidney impairment
  • Liver impairment
  • Hyperlysinemia or hyperlysinuria
  • Glutaric aciduria type 1
  • Pyridoxine-dependent epilepsy (ALDH7A1 deficiency)
  • Asthma provoked by aspirin or related anti-inflammatory drugs, active peptic ulcer, prior stomach bleeding or perforation on these drugs, or bleeding disorders (aspirin lysinate)
  • Severe organ impairment and late pregnancy (aspirin lysinate): creatinine clearance below 30 mL/min, severe liver impairment, severe uncontrolled heart failure, mastocytosis, pregnancy beyond 24 weeks at doses above 100 mg/day
Key Interactions
  • Calcium supplements and calcium-based antacids (calcium carbonate): higher calcium load
  • Meals with drug lysinates (ibuprofen lysinate): slower onset of pain relief
  • Carbohydrate-rich meals and glucose drinks: smaller glucose rise
  • Oral anticoagulants and methotrexate with aspirin lysinate (warfarin; methotrexate above 20 mg/week): added bleeding; methotrexate toxicity
  • Diuretics and amikacin with ibuprofen lysinate (furosemide): kidney strain; amikacin build-up
  • Other antiplatelet drugs, heparins and SSRIs with aspirin lysinate (clopidogrel; enoxaparin; sertraline): bleeding
  • Glucocorticoids and valproic acid with aspirin lysinate (prednisolone; valproate): bleeding; valproate toxicity
  • Anti-inflammatory pain relievers and antacids with aspirin lysinate (ibuprofen; calcium carbonate): stomach bleeding; weaker aspirin effect
Theoretical (inferred from mechanism)
  • Aminoglycoside antibiotics (gentamicin, amikacin): added kidney injury
  • Nonsteroidal anti-inflammatory drugs (ibuprofen, naproxen): kidney strain, mainly with dehydration
  • Glucose-lowering drugs (metformin, insulin): lower glucose
  • Arginine supplements and arginine-rich foods (L-arginine, nuts): weaker proposed antiviral effect
  • Vitamin D and other calcium-absorption enhancers: excess calcium uptake with high calcium intake
  • Berberine and chromium: lower glucose
  • Other mineral supplements alongside mineral lysinates (zinc, magnesium): intake above mineral upper limits

Risk & Side Effects

  • High: Kidney strain with drug lysinates
  • Medium: Stomach and gut injury with drug lysinates; other adverse events in premature infants with ibuprofen lysinate
  • Low: Gastrointestinal upset; kidney tubule injury; heart and vascular events with ibuprofen lysinate; bleeding with drug lysinates; asthma and allergic reactions with aspirin lysinate; serious skin and hypersensitivity reactions with ibuprofen lysinate; liver injury with aspirin lysinate; gout attacks with aspirin lysinate; pulmonary hypertension in premature infants with ibuprofen lysinate; infection masking and sepsis in premature infants with ibuprofen lysinate; hemolysis in G6PD deficiency with aspirin lysinate; tinnitus and hearing loss with high-dose aspirin lysinate; blood-cell disorders with aspirin lysinate; Reye's syndrome in children and adolescents with aspirin lysinate; fetal harm in late pregnancy with drug lysinates; high blood potassium with infused lysine and arginine; other label-listed reactions with aspirin lysinate
  • Speculative: Reduced arginine availability and nitric oxide; concerns in cardiovascular and gallbladder disease; bilirubin displacement in premature infants with ibuprofen lysinate

Monitoring

Marker Target Why
Serum creatinine About 0.6–1.2 mg/dL, lab-specific Safety check: a rise stops use
Urinalysis (glucose, protein) Negative for glucose and protein Safety check: new glucose or protein stops use
Serum calcium 8.5–10.2 mg/dL Safety check with calcium lysinate or added calcium
HbA1c 4.0–5.6% Expected to change if blood-sugar effects occur
Estimated glomerular filtration rate (eGFR) Not specified in the ER Kidney filtering capacity, paired with creatinine
Serum albumin Not specified in the ER Paired with serum calcium
Fasting glucose Not specified in the ER Paired with HbA1c

Cadence: Baseline before gram-level intake; kidney tests and urinalysis at 3 months, then every 6–12 months; serum calcium at 3 months with calcium lysinate; HbA1c after 3 months. These cadences follow common practice rather than trial protocols. Drug lysinates follow the parent drug's monitoring.

Qualitative Assessment

  • Cold-sore frequency, duration and severity, tracked in a diary against the prior year
  • Perceived stress and anxiety, rated weekly
  • Gastrointestinal comfort (nausea, bloating, stool changes)
  • Energy and fluid balance (unusual thirst or urination can signal tubule problems)